IL147261A0 - Ambroxol-containing lozenge - Google Patents

Ambroxol-containing lozenge

Info

Publication number
IL147261A0
IL147261A0 IL14726100A IL14726100A IL147261A0 IL 147261 A0 IL147261 A0 IL 147261A0 IL 14726100 A IL14726100 A IL 14726100A IL 14726100 A IL14726100 A IL 14726100A IL 147261 A0 IL147261 A0 IL 147261A0
Authority
IL
Israel
Prior art keywords
tablet
ambroxol
pressing
containing lozenge
amobroxol
Prior art date
Application number
IL14726100A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7914872&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL147261(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL147261A0 publication Critical patent/IL147261A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dry Formation Of Fiberboard And The Like (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Cosmetics (AREA)
  • Confectionery (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
IL14726100A 1999-07-20 2000-07-07 Ambroxol-containing lozenge IL147261A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19933148A DE19933148A1 (de) 1999-07-20 1999-07-20 Ambroxolhaltige Lutschtablette
PCT/EP2000/006437 WO2001005378A1 (de) 1999-07-20 2000-07-07 Ambroxolhaltige lutschtablette

Publications (1)

Publication Number Publication Date
IL147261A0 true IL147261A0 (en) 2002-08-14

Family

ID=7914872

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14726100A IL147261A0 (en) 1999-07-20 2000-07-07 Ambroxol-containing lozenge
IL147261A IL147261A (en) 1999-07-20 2001-12-23 A pill containing ambroxol

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL147261A IL147261A (en) 1999-07-20 2001-12-23 A pill containing ambroxol

Country Status (33)

Country Link
US (1) US6663889B1 (pl)
EP (2) EP1200070B1 (pl)
JP (1) JP3776041B2 (pl)
KR (1) KR100743846B1 (pl)
CN (1) CN1164263C (pl)
AT (1) ATE246493T1 (pl)
AU (1) AU776906B2 (pl)
BG (1) BG65503B1 (pl)
BR (1) BRPI0012553B8 (pl)
CA (1) CA2379314C (pl)
CZ (1) CZ301981B6 (pl)
DE (2) DE19933148A1 (pl)
DK (1) DK1200070T3 (pl)
EA (1) EA004044B1 (pl)
EE (1) EE04797B1 (pl)
ES (1) ES2173823T3 (pl)
HK (1) HK1045946B (pl)
HR (1) HRP20020050B1 (pl)
HU (1) HU229040B1 (pl)
IL (2) IL147261A0 (pl)
ME (1) MEP36808A (pl)
MX (1) MXPA02000546A (pl)
NO (1) NO331306B1 (pl)
NZ (1) NZ516987A (pl)
PL (1) PL197175B1 (pl)
PT (1) PT1200070E (pl)
RS (1) RS50246B (pl)
SI (1) SI1200070T1 (pl)
SK (1) SK284290B6 (pl)
TR (1) TR200200106T2 (pl)
UA (1) UA73313C2 (pl)
WO (1) WO2001005378A1 (pl)
ZA (1) ZA200200384B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10125883A1 (de) 2001-05-28 2002-12-12 Serumwerk Bernburg Ag Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie
DE10208313A1 (de) * 2002-02-27 2003-09-11 Boehringer Ingelheim Pharma Ambroxol für die Behandlung von schmerzhaften Zuständen im Mund und Rachenraum
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
US20050075403A1 (en) * 2003-10-02 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of inflammation in the pharynx
ITMI20032463A1 (it) * 2003-12-16 2005-06-17 Advance Holdings Ltd Soluzione acquosa concentrata a base di ambroxolo
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
DE102004021992A1 (de) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
DE102005018561A1 (de) * 2005-04-21 2006-11-02 Giesecke & Devrient Gmbh Verfahren zum Betreiben eines Systems mit einem tragbaren Datenträger und einem Endgerät
DE102010009369A1 (de) 2010-02-25 2011-08-25 Boehringer Ingelheim International GmbH, 55218 Kindergesicherte Verpackung für Ambroxolhaltige Lutschtabletten
KR20130140042A (ko) 2010-12-23 2013-12-23 렉티오 파르마엔트빅클룽스-운트 페르베르퉁스 게엠베하 암브록솔의 수용액
KR102076585B1 (ko) 2011-12-22 2020-02-12 센토제너 아이피 게엠베하 리소좀 효소를 재배열하는 능력을 갖는 화합물 및 암브록솔 및/또는 암브록솔의 유도체의 조합물
WO2018089797A1 (en) 2016-11-14 2018-05-17 Mingwu Wang Formulations for the treatment of ocular surface diseases and related methods
MX2017014725A (es) * 2017-11-16 2019-05-17 Productos Farm S A De C V Dropropizina en combinacion con ambroxol en la forma farmaceutica de jarabe y tabletas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034975C2 (de) * 1980-09-17 1986-11-27 Dr. Karl Thomae Gmbh, 7950 Biberach Arzneimittelkombination zur Behandlung infektiöser Atemwegerkrankungen
DE3432411A1 (de) * 1983-09-17 1985-04-11 Dr. Karl Thomae Gmbh, 7950 Biberach Antiadhaesive prohylactica und arzneimittel, enthaltend ein sekretolytisch wirksames benzylaminderivat
IT1252185B (it) * 1991-12-11 1995-06-05 Therapicon Srl Preparazioni farmaceutiche a liberazione programmata
DE4420735C2 (de) * 1994-06-15 1996-09-05 Allphamed Arzneimittel Gmbh Verfahren zur Herstellung mechanisch stabiler, sich mit hoher Auflösegeschwindigkeit auszeichnender Brausetabletten
DE19648576C2 (de) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt

Also Published As

Publication number Publication date
MXPA02000546A (es) 2002-07-30
PL352276A1 (en) 2003-08-11
KR20020012316A (ko) 2002-02-15
NO20020274D0 (no) 2002-01-18
CZ301981B6 (cs) 2010-08-25
EE04797B1 (et) 2007-04-16
NO331306B1 (no) 2011-11-21
IL147261A (en) 2006-12-31
NO20020274L (no) 2002-03-13
HUP0202021A3 (en) 2004-05-28
DK1200070T3 (da) 2003-10-06
SI1200070T1 (en) 2003-12-31
WO2001005378A1 (de) 2001-01-25
BRPI0012553B8 (pt) 2021-05-25
US6663889B1 (en) 2003-12-16
PT1200070E (pt) 2003-12-31
BR0012553A (pt) 2002-04-16
CZ20014633A3 (cs) 2002-03-13
DE19933148A1 (de) 2001-01-25
EP1200070A1 (de) 2002-05-02
CN1164263C (zh) 2004-09-01
ES2173823T1 (es) 2002-11-01
EA004044B1 (ru) 2003-12-25
MEP36808A (en) 2011-02-10
AU6269900A (en) 2001-02-05
DE50003209D1 (de) 2003-09-11
CN1364075A (zh) 2002-08-14
BR0012553B1 (pt) 2014-05-27
BG106316A (en) 2002-08-30
ZA200200384B (en) 2002-10-30
UA73313C2 (uk) 2005-07-15
JP2003522125A (ja) 2003-07-22
EE200200027A (et) 2003-04-15
SK812002A3 (en) 2002-06-04
EP1352646A3 (de) 2004-01-07
ES2173823T3 (es) 2004-04-16
BG65503B1 (bg) 2008-10-31
EP1352646A2 (de) 2003-10-15
AU776906B2 (en) 2004-09-23
JP3776041B2 (ja) 2006-05-17
HRP20020050B1 (en) 2004-06-30
RS50246B (sr) 2009-07-15
EA200200091A1 (ru) 2002-06-27
HK1045946B (zh) 2005-01-28
PL197175B1 (pl) 2008-03-31
CA2379314A1 (en) 2001-01-25
NZ516987A (en) 2003-08-29
CA2379314C (en) 2007-09-11
YU3802A (sh) 2004-09-03
HRP20020050A2 (en) 2003-06-30
SK284290B6 (sk) 2005-01-03
HU229040B1 (en) 2013-07-29
HUP0202021A2 (hu) 2002-11-28
KR100743846B1 (ko) 2007-08-02
ATE246493T1 (de) 2003-08-15
TR200200106T2 (tr) 2002-07-22
EP1200070B1 (de) 2003-08-06
HK1045946A1 (en) 2002-12-20

Similar Documents

Publication Publication Date Title
HRP20020050B1 (en) Ambroxol-containing lozenge
DE69626660D1 (en) 2-alkylpyrrolidine
CA2472194A1 (en) An inhalation actuated device
EP0960621A3 (en) Pharmaceutical formulations comprising sildenafil
GB2298162A (en) Padding
IL151690A0 (en) Medicaments for complications of diabetes and neuropathy, and uses thereof
DE69432789D1 (de) Pharmazeutische zusammensetzungen zur intranasalen verabreichung von apomorphin
DK0996653T3 (da) Phenolresin til limsammensætning, fremgangsmåde til fremstilling deraf og limsammensætning indeholdende den
CA2377755A1 (en) Pneumatic breath actuated inhaler
WO2003051293A3 (en) Antidiabetic formulation and method
GR3018245T3 (en) An adhesive composition comprising isocyanate, phenol-formaldehyde and tannin, useful for manufacturing plywoods for exterior application.
ZA971663B (en) Porcine reproductive and respiratory syndrome vaccine.
AU2001235595A1 (en) 4-heteroaryl-1,4-diazabicyclo(3.2.2)nonane, preparation and therapeutic use thereof
WO2001026638A3 (en) The use of baclofen in the treatment of alcoholism
AU2791689A (en) Medicinal preparation comprising the association of colistin,tobramycin and amphotericin b administered by atomization
WO2002057313A8 (en) Receptor-binding compounds and methods for identifying them
WO2002005200A8 (en) A method, an apparatus, and a composition for customizing the combination of fragrances
AU2001259295A1 (en) Method and composition for rapid delivery of bioactive compounds to the systemiccirculation via the nasal membrane
CA2179234A1 (en) Moisture-Cure Urethane Adhesive Containing Gamma-Butyrolactone
WO2001092270A3 (en) An improved method for the preparation of hexafluoroacetone
WO2001032201A3 (en) A pharmaceutical composition having high cell membrane permeability
AU3110595A (en) Exchangeable mouthpiece for inhalers with integrated, consolidated, ring-shaped active substance tablet
UA35126A (uk) Композиція інгредієнтів для горілки "українська пшениця"
AU4635801A (en) Plaster containing an active agent
TW272958B (en) A manufacturing method for making re-enforced composite construction panel

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed